157 related articles for article (PubMed ID: 2165400)
1. Identification and selective inhibition of four distinct soluble forms of cyclic nucleotide phosphodiesterase activity from kidney.
Hoey M; Houslay MD
Biochem Pharmacol; 1990 Jul; 40(2):193-202. PubMed ID: 2165400
[TBL] [Abstract][Full Text] [Related]
2. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
Lavan BE; Lakey T; Houslay MD
Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
[TBL] [Abstract][Full Text] [Related]
3. Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue.
Price B; Pyne NJ; Houslay MD
Biochem Pharmacol; 1987 Dec; 36(23):4047-54. PubMed ID: 2825712
[TBL] [Abstract][Full Text] [Related]
4. The presence of five cyclic nucleotide phosphodiesterase isoenzyme activities in bovine tracheal smooth muscle and the functional effects of selective inhibitors.
Shahid M; van Amsterdam RG; de Boer J; ten Berge RE; Nicholson CD; Zaagsma J
Br J Pharmacol; 1991 Oct; 104(2):471-7. PubMed ID: 1665737
[TBL] [Abstract][Full Text] [Related]
5. Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors.
Komas N; Lugnier C; Stoclet JC
Br J Pharmacol; 1991 Oct; 104(2):495-503. PubMed ID: 1665741
[TBL] [Abstract][Full Text] [Related]
6. Cyclic nucleotide phosphodiesterases from rat anterior pituitary. Characterization of multiple forms and regulation by protein activator and Ca+.
Azhar S; Menon KM
Eur J Biochem; 1977 Feb; 73(1):73-82. PubMed ID: 190011
[TBL] [Abstract][Full Text] [Related]
7. Multiple forms of cyclic nucleotide phosphodiesterase in pig epidermis.
Adachi K; Levine V; Halprin KM; Iizuka H; Yoshikawa K
Biochim Biophys Acta; 1976 Apr; 429(2):498-507. PubMed ID: 4133
[TBL] [Abstract][Full Text] [Related]
8. Cyclic nucleotide phosphodiesterase in rat neostriatum: multiple isoelectric forms with similar kinetic properties.
Minneman KP
J Neurochem; 1976 Nov; 27(5):1181-9. PubMed ID: 12170605
[TBL] [Abstract][Full Text] [Related]
9. Cellular distribution of phosphodiesterase isoforms in rat cardiac tissue.
Bode DC; Kanter JR; Brunton LL
Circ Res; 1991 Apr; 68(4):1070-9. PubMed ID: 1849058
[TBL] [Abstract][Full Text] [Related]
10. Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle.
Barnette MS; Manning CD; Price WJ; Barone FC
J Pharmacol Exp Ther; 1993 Feb; 264(2):801-12. PubMed ID: 7679736
[TBL] [Abstract][Full Text] [Related]
11. The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors.
Reeves ML; Leigh BK; England PJ
Biochem J; 1987 Jan; 241(2):535-41. PubMed ID: 3036066
[TBL] [Abstract][Full Text] [Related]
12. Separation and characterization of a novel isoenzyme of cyclic nucleotide phosphodiesterase from rat cerebrum.
Mukai J; Asai T; Naka M; Tanaka T
Br J Pharmacol; 1994 Feb; 111(2):389-90. PubMed ID: 8004382
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of isoenzymes of cyclic nucleotide phosphodiesterase in human kidney and heart, and the effects of new cardiotonic agents on these isoenzymes.
Sugioka M; Ito M; Masuoka H; Ichikawa K; Konishi T; Tanaka T; Nakano T
Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):284-93. PubMed ID: 7824045
[TBL] [Abstract][Full Text] [Related]
14. Human blood platelet 3': 5'-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase.
Hidaka H; Asano T
Biochim Biophys Acta; 1976 Apr; 429(2):485-97. PubMed ID: 177073
[TBL] [Abstract][Full Text] [Related]
15. Purification, characterization and production of rabbit antibodies to rat liver particulate, high-affinity, cyclic AMP phosphodiesterase.
Whitson RH; Appleman MM
Biochim Biophys Acta; 1982 Feb; 714(2):279-91. PubMed ID: 6275911
[TBL] [Abstract][Full Text] [Related]
16. Catalytic and regulatory properties of two forms of bovine heart cyclic nucleotide phosphodiesterase.
Ho C; Teo TS; Desai R; Wang JH
Biochim Biophys Acta; 1976 Apr; 429(2):461-73. PubMed ID: 177071
[TBL] [Abstract][Full Text] [Related]
17. 3',5'-Cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition.
Drees M; Zimmermann R; Eisenbrand G
Cancer Res; 1993 Jul; 53(13):3058-61. PubMed ID: 8391385
[TBL] [Abstract][Full Text] [Related]
18. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
Kelly JJ; Barnes PJ; Giembycz MA
Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
[TBL] [Abstract][Full Text] [Related]
19. The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re-uptake site.
Nicholson CD; Jackman SA; Wilke R
Br J Pharmacol; 1989 Jul; 97(3):889-97. PubMed ID: 2474352
[TBL] [Abstract][Full Text] [Related]
20. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages.
Turner NC; Wood LJ; Burns FM; Gueremy T; Souness JE
Br J Pharmacol; 1993 Apr; 108(4):876-83. PubMed ID: 8387385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
